Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores

Journal of Invasive Cardiology

Volumn 15, Issue 9, 2003, Pages 502-506

  Almeda, Francis Q ^b   Hendel, Robert C ^b   Nathan, Sandeep ^b   Meyer, Peter M ^b   Calvin, James E ^b   Klein, Lloyd W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acute coronary syndromes; Myocardial infarction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN; TROPONIN I;

ACUTE CORONARY SYNDROME; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY STENT; CREATININE BLOOD LEVEL; DRUG FATALITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TIMI RISK SCORE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITAL MORTALITY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0141590218     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-842.
2. Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 2000;284:876-878.
3. Brindis RG, Fitzgerald S, Anderson HV, et al. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): Building a national clinical data repository. J Am Coll Cardiol 2001;37:2240-2245.
4. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-2130.
5. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997;337:447-452.
6. Antman EM. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. Am Heart J 1998;135:S353-360.
7. Almeda FQ, Sncll RJ, Parrillo JE. The contemporary management of acute myocardial infarction. Clin Care Clin 2001;17:411-434.
8. Zaacks SM, Liebson PR, Calvin JE, et al. Unstable angina and non-Q wave myocardial infarction: Does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol 1999;33:107-118.
9. Almeda FQ, Calvin JE, Parrillo JE, et al. Prevalence of angiographically significant srenosis in patients with chest pain and an elevated troponin I level and normal creatine kinase and creatine kinase-MB levels. Am J Cardiol 2001;87:1286-1289.
10. Braunwald E, Jones RH, Mark DB, et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994;90:613-622.
11. Calvin JE, Klein LW, VandenBerg EJ, et al. Validated risk stratification model accurately predicts low risk in patients with unstable angina. J Am Coll Cardiol 2000;36:1803-1808.
12. Calvin JE, Klein LW, VandenBerg BJ, et al. Risk stratification in unstable angina. Prospective validation of the Braunwald classification. J Am Med Assoc 1995;273:136-141.
13. Braunwald E, Antman EM, Beasley JW, et al. ACCIAHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
14. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-698.
15. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998;338:1488-1497.
16. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436-443.
17. Roe MT, Sapp SK, Lincoff AM. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleve Clin J Med 2000;67:131-140.
18. Kleiman NS, Lincoff AM, Ohman EM, Harrington RA. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: Pathophysiologic foundation and clinical findings. Am Heart J 1998;136:S32-S42.
19. Cannon CP, Weintraub WS, Demopoulos LA, et al. Invasive versus conservative strategies in unstable angina and non-Q- wave myocardial infarction following treatment with tirofiban: Rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction. Am J Cardiol 1998;82:731-736.
20. Diderholm E, Andren B, Frostfeldt G, et al. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; The FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease. Eur Heart J 2002;23:41-49.
21. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999;100:1602-1608.